BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25531193)

  • 21. EP2 and EP3 receptors as therapeutic targets for underactive bladder/detrusor underactivity due to diabetic cystopathy in a type 1 diabetic rat model.
    Sekido N; Otsuki T; Kida J; Mashimo H; Wakamatsu D; Okada H; Matsuya H
    Low Urin Tract Symptoms; 2020 Sep; 12(3):285-291. PubMed ID: 32410343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity.
    Dasgupta R
    BJU Int; 2004 Jul; 94(1):191-2. PubMed ID: 15217463
    [No Abstract]   [Full Text] [Related]  

  • 23. Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study.
    Skolarikos A; Tyritzis S; Stamatiou K
    Minerva Urol Nefrol; 2012 Sep; 64(3):209-16. PubMed ID: 22971686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholinergic crisis following administration of distigmine bromide: a case report].
    Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
    Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute poisoning due to distigmine bromide].
    Onodera M
    Chudoku Kenkyu; 2008 Apr; 21(2):161-7. PubMed ID: 18516941
    [No Abstract]   [Full Text] [Related]  

  • 26. Conscious voiding during bladder obstruction in guinea pigs correlates with contractile activity of isolated bladders.
    Nicholas S; Keightley L; Brookes S; Costa M; Gibbins I; Zagorodnyuk V
    Auton Neurosci; 2015 Dec; 193():74-83. PubMed ID: 26282433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder.
    Pagala MK; Tetsoti L; Nagpal D; Wise GJ
    J Urol; 2001 Aug; 166(2):721-7. PubMed ID: 11458124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of distigmine at 5 mg daily in patients with detrusor underactivity].
    Sugaya K; Kadekawa K; Onaga T; Ashitomi K; Mukouyama H; Nakasone K; Shimabukuro H; Shimabukuro S; Matayoshi Y; Hokama S; Touyama Y; Nishijima S
    Nihon Hinyokika Gakkai Zasshi; 2014 Jan; 105(1):10-6. PubMed ID: 24605581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder.
    Soukup O; Pohanka M; Tobin G; Jun D; Fusek J; Musilek K; Marek J; Kassa J; Kuca K
    Neuro Endocrinol Lett; 2008 Oct; 29(5):759-62. PubMed ID: 18987577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced therapeutic directions to treat the underactive bladder.
    Smith PP; Tyagi P; Kuchel GA; Pore S; Chermansky C; Chancellor M; Yoshimura N; Levanovich P
    Int Urol Nephrol; 2014 Sep; 46 Suppl 1():S35-44. PubMed ID: 25238893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of bethanechol on canine urinary bladder smooth muscle function.
    Buranakarl C; Kijtawornrat A; Angkanaporn K; Komolvanich S; Bovee KC
    Res Vet Sci; 2001 Dec; 71(3):175-81. PubMed ID: 11798291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity.
    Hindley RG; Brierly RD; Thomas PJ
    BJU Int; 2004 Jan; 93(1):89-92. PubMed ID: 14678375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bethanechol: Is it still being prescribed for bladder dysfunction in women?
    Gaitonde S; Malik RD; Christie AL; Zimmern PE
    Int J Clin Pract; 2019 Aug; 73(8):e13248. PubMed ID: 30112787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Three cases of cholinergic crisis in which serum distigmine bromide concentrations were measured].
    Onodera M; Fujino Y; Inoue Y; Endo S; Fujita Y
    Chudoku Kenkyu; 2008 Jan; 21(1):75-81. PubMed ID: 18277557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bethanechol-responsive bladder atony in a colt foal after cystorrhaphy for cystorrhexis.
    Booth TM; Howes DA; Edwards GB
    Vet Rec; 2000 Sep; 147(11):306-8. PubMed ID: 11037734
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of distigmine bromide on the central cholinergic system.
    Nakayama K; Katsu H; Kitazumi K
    J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an EP2 and EP3 Receptor Dual Agonist, ONO-8055, on a Radical Hysterectomy-Induced Underactive Bladder Model in Monkeys.
    Matsuya H; Sekido N; Kida J; Mashimo H; Wakamatsu D; Okada H
    Low Urin Tract Symptoms; 2018 May; 10(2):204-211. PubMed ID: 28439968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New technology assessment and current and upcoming therapies for underactive bladder.
    Chancellor MB; Bartolone SN; DeVries EM; Diokno AC; Gibbons M; Jankowski R; Lamb LE; Pruchnic R; Thor K; Dmochowski R
    Neurourol Urodyn; 2018 Nov; 37(8):2932-2937. PubMed ID: 29953660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary report on the effect of distigmine bromide on the neurogenic bladder.
    Yeo J; Southwell P; Hindmarsh E
    Med J Aust; 1973 Jan; 1(3):116-20. PubMed ID: 4690345
    [No Abstract]   [Full Text] [Related]  

  • 40. Opacification of urinary bladder and ureter at CT urography: effect of a log-rolling procedure and postvoiding residual bladder urine volume.
    Kim S; Wang LL; Heiken JP; Siegel CL; Hildebolt CF; Bae KT
    Radiology; 2008 Jun; 247(3):747-53. PubMed ID: 18413887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.